Projects per year
Abstract
α-Methylacyl-CoA racemase (AMACR; P504S) regulates branched-chain fatty acid degradation, activates Ibuprofen and is a recognised cancer drug target. A novel, facile colorimetric assay was developed based on elimination of 2,4-dinitrophenolate. The assay was used to test 5 known inhibitors, determining IC50 and Ki values, reversibility and characterize irreversible inhibition.
Original language | English |
---|---|
Pages (from-to) | 5087-5090 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 53 |
Issue number | 37 |
Early online date | 17 Mar 2017 |
DOIs | |
Publication status | Published - 7 May 2017 |
Fingerprint
Dive into the research topics of 'A novel colorimetric assay for α-methylacyl-CoA racemase 1A (AMACR; P504S) utilizing the elimination of 2,4-dinitrophenolate'. Together they form a unique fingerprint.Projects
- 2 Finished
-
AMACR Targeted Drugs for Treating Advance Prostate Cancer
James, T. (PI)
1/02/15 → 31/01/18
Project: UK charity
-
AMACR Targeted Drugs for Treating Advance Prostate Cancer
Lloyd, M. (PI), James, T. (CoI), Jevglevskis, M. (CoI), Nathubhai, A. (CoI), Threadgill, M. (CoI) & Woodman, T. (CoI)
1/02/15 → 30/07/18
Project: UK charity
Profiles
Equipment
-
Avance III 500 MHz Nuclear Magnetic Resonance (NMR) Spectrometer (9West)
Material and Chemical Characterisation (MC2)Facility/equipment: Equipment
-
MC2- Nuclear Magnetic Resonance (NMR)
Material and Chemical Characterisation (MC2)Facility/equipment: Technology type